Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

219 Downloads (Pure)

Abstract

Background: Some studies indicate a reduced risk of serious upper gastrointestinal bleeding (UGIB) for users of beta-blockers, but the association remains to be confirmed in larger studies and characterized with respect to differences among beta-blockers. We aimed to assess whether beta-blocker use decreases the risk of UGIB.

Methods: We conducted a register-based, population-based case-control study in Denmark. We identified cases with a first validated discharge diagnosis of UGIB during the period 1995-2006. Controls were selected by risk-set sampling in a ratio of 10:1. We estimated crude and adjusted odds ratios (ORs) of the association between current beta-blocker use and the risk of UGIB by using conditional logistic regression and further stratified by selective and non-selective beta-blockers, respectively.

Results: We identified 3571 UGIB cases and 35,582 controls. Use of beta-blockers was not found to be associated with a decreased risk of UGIB (adjusted OR 1.10; 95% CI: 1.00-1.21). The association remained neutral after stratification by selective and non-selective beta-blockers, and by single beta-blocker substances. Similarly, we found no association between current beta-blocker use and the risk of UGIB within different subgroups.

Conclusions: We found no association between beta-blocker use and UGIB.

OriginalsprogEngelsk
TidsskriftTherapeutic Advances in Gastroenterology
Vol/bind10
Udgave nummer12
Sider (fra-til)919-929
ISSN1756-283X
DOI
StatusUdgivet - 2017

Fingeraftryk

Dyk ned i forskningsemnerne om 'Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control study'. Sammen danner de et unikt fingeraftryk.

Citationsformater